EXOMIND™

Exomind is a cutting-edge brain stimulation treatment that harnesses the power of electromagnetic pulses to activate specific regions of the brain linked to mood, focus, and emotional balance. FDA-cleared and non-invasive, this innovative approach helps rewire neural pathways, promoting long-term relief from depression, anxiety, and cognitive fatigue — all without medications or downtime.

FDA-cleared for the treatment of depression†, the EXOMIND’s patented ExoTMS™ technology comfortably stimulates key areas of the brain involved in emotional regulation, cognitive function, and self-control. By activating neural pathways, it helps restore healthy brain activity and enhances neural connectivity.

ExoMind™ by BTL Industries is a next-generation form of transcranial magnetic stimulation (TMS) that applies precisely shaped ExoTMS™ pulses to the brain’s mood-regulating networks, building on more than two decades of clinical TMS experience to shorten sessions and maximize comfort exomindlife.com. The platform is cleared by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder, giving adults who have not achieved satisfactory relief with medication a proven, non-pharmacological option prnewswire.com & fda.report.

Because most people who consider ExoMind are already taking at least one antidepressant, our clinic can now offer a pathway that enhances well-being and may reduce reliance on daily medication while keeping patients under physician supervision.